Margaret Moore, MD
Hematopathology; Assistant Professor
Department: Pathology
Phone: 804-628-5780
Fax: 804-828-2812
Email: Margaret.Moore@vcuhealth.org
Margaret Moore, MD is an assistant professor of pathology at Virginia Commonwealth University Health System.
Dr. Moore completed medical school, Anatomic and Clinical Pathology Residency, and Hematopathology Fellowship at the University of Virginia in Charlottesville, Virginia. She then practiced as a surgical pathologist and hematopathologist at UVA for one year, prior to accepting her current appointment at VCU.
Her clinical and research interests include benign and malignant disorders of the blood, bone marrow, and lymphoid tissues. She has authored multiple peer-reviewed articles, as well as educational hematopathology modules. She enjoys working with trainees of all levels.
Clinical Specialties: Hematopathology and Surgical Pathology
Contact Dr. Moore for a full CV
Print/Download Dr. Moore Web CV (pdf)
Dr. Margaret Moore abbreviated CV
Education
2023 - 2024 Hematopathology Fellow, University of Virginia, Charlottesville, Virginia
2019 - 2023 Resident, Anatomic and Clinical Pathology, University of Virginia, Charlottesville, Virginia
2015 - 2019 Doctor of Medicine, University of Virginia, Charlottesville, Virginia
2010 - 2014 Bachelor of Science in Biochemistry, summa cum laude, University of Richmond, Richmond, Virginia
Licenses & Certifications
October 2022 - Present: Virginia Medical License
Selected Awards & Honors
June 2023 UVA Resident Citizenship Award
April 2023 UVA Pathology Research Day, Best Clinical Research Poster
May 2019 Dr. James R. Cash Pathology Book Award
January 2017 Alpha Omega Alpha Honor Society
Professional Service (outside)
July 2025 - present International Clinical Cytometry Society
April 2023 - present Society for Hematopathology
January 2020 - present American Society of Clinical Pathology
January 2020 - present United States and Canadian Academy of Pathology
July 2019 - present Virginia Society for Pathology
July 2019 - present College of American Pathologists
Selected Publications
Peer Reviewed
Chaudhary S, Courville EL, Craig J, Smith V, Moore M. Immunohistochemical evaluation of T cell receptor and T cell receptor beta constant 1 expression distinguishes benign and neoplastic immature T-cell populations and reveals discrete TRBC1/TCR phenotypes. Journal of Hematopathology. 2025;18(1):61. doi:10.1007/s12308-025-00674-2
Luniewski A, Moore M, Williams ES, et al. Distinctive genomic features of hydroa vacciniforme lymphoproliferative disorder in Latin American patients: A multicenter multi-omics study. Journal of the American Academy of Dermatology. Published online October 2025:S0190962225029718. doi:10.1016/j.jaad.2025.10.026
Moore M, Courville EL. Recognizing non-neoplastic mimics of myeloid malignancies in the bone marrow and peripheral blood: pearls and pitfalls. Diagnostic Histopathology. 2025;31(10):609-622. doi:10.1016/j.mpdhp.2025.07.004
Moore M, Courville EL. Recognizing non-neoplastic mimics of lymphoid malignancies in the bone marrow and peripheral blood: pearls and pitfalls. Diagnostic Histopathology. 2025;31(10):597-608. doi:10.1016/j.mpdhp.2025.07.003
Moore M, Patel P, Tao J. Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia. J Hematopathol. 2024;17(4):223-225. doi:10.1007/s12308-024-00609-3
Moore M, Aguilera NS, Obiorah I, et al. Assessment for acceleration and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma using histologic and immunohistochemical features: a case series. J Hematopathol. 2024;17(3):139-147. doi:10.1007/s12308-024-00598-3
Moore M, Chen X, Sadigh S, et al. Evaluating pathologist practices in peripheral blood smear review: A comprehensive practice survey. American Journal of Clinical Pathology. Published online July 22, 2024:aqae091. doi:10.1093/ajcp/aqae091
Moore M, Williams E, Pelkey L, et al. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists. Cancer Genetics. 2024;286-287:25-28. doi:10.1016/j.cancergen.2024.06.003.
Moore M, Courville E, Prakash S, et al. An interactive e-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. American Journal of Clinical Pathology. 2023;aqad014.
Moore M, Courville E. Work-up of patients with decreased hemoglobin A2 identified by capillary zone electrophoresis, a North American institutional experience. Laboratory Medicine. 2022;XX:e0–e6.
Abstracts and Presentations
* Indicates meeting presenter
Chaudhary S, Das I, Courville E, Obiorah I, Laser J, Moore M, Craig J. 1172 Exploring the efficacy of TRBC1 and TRBC2 mRNA BaseScope for in situ T-cell clonality assessment in diverse T-cell malignancies. Laboratory Investigation. 2026;106(3):105464. doi:10.1016/j.labinv.2025.105464
Chaudhary S, Courville, EC, Craig J, Smith V, Moore M. Immunohistochemical evaluation of TRBC1 expression in T-lymphoblastic leukemia/lymphoma. College of American Pathologists 2025 annual meeting(Cap25). Archives of Pathology & Laboratory Medicine. 2025;149(8):e161-e289. doi:10.5858/arpa.2025-0194-AB
Bolte F, Natale N, DiBenedetto S, Moore M, et al. Spatial transcriptomics of the tumor microenvironment reveals different interferon-related gene signatures in tumor endothelial cells of patients with EGFR and KRAS mutant non-small cell lung cancer. Submitted to American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.
Moore M, Courville E, Craig J, et al. Characteristic blast morphology and immunophenotype assist in identification of trisomy 21 in a setting of limited prenatal care. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.
Moore M, Aguilera N. Peripheral T-cell lymphoma, not otherwise specified, in a robust histiocytic background, an unusual presentation with Pott’s-Puffy tumor. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.
*Moore M. Society for hematopathology education committee results: Pathologist practices in peripheral blood smear review. Society for Hematopathology Program Directors Meeting. USCAP 2024.
Pelkey L, Moore M, El Chaer F, et al. A comparison of World Health Organization and International Consensus Classification systems for myeloid neoplasms and implications for pathology reporting. Abstracts and Case studies from the College of American pathologists 2023 annual meeting(Cap23). Archives of Pathology & Laboratory Medicine. 2023;147(9):e2-e154
*Moore M, Prakash S, Brown L, et al. An interactive E-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. USCAP 2023 abstracts education. Laboratory Investigation. 2023;103(3):100086.
*Moore M, Aguilera N, Obiorah I, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with features of acceleration/transformation is difficult to define by histologic or immunohistochemical criteria. USCAP 2023 abstracts hematopathology. Laboratory Investigation. 2023;103(3):100106.
Bolte F, Natale N, DiBenedetto S, Moore M, et al. Spatial transcriptomics of the tumor microenvironment reveals different interferon-related gene signatures in tumor endothelial cells of patients with EGFR and KRAS mutant non-small cell lung cancer. Submitted to American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.
Moore M, Courville E, Craig J, et al. Characteristic blast morphology and immunophenotype assist in identification of trisomy 21 in a setting of limited prenatal care. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.
Moore M, Aguilera N. Peripheral T-cell lymphoma, not otherwise specified, in a robust histiocytic background, an unusual presentation with Pott’s-Puffy tumor. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.
*Moore M. Society for hematopathology education committee results: Pathologist practices in peripheral blood smear review. Society for Hematopathology Program Directors Meeting. USCAP 2024.
Pelkey L, Moore M, El Chaer F, et al. A comparison of World Health Organization and International Consensus Classification systems for myeloid neoplasms and implications for pathology reporting. Abstracts and Case studies from the College of American pathologists 2023 annual meeting(Cap23). Archives of Pathology & Laboratory Medicine. 2023;147(9):e2-e154
*Moore M, Prakash S, Brown L, et al. An interactive E-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. USCAP 2023 abstracts education. Laboratory Investigation. 2023;103(3):100086.
*Moore M, Aguilera N, Obiorah I, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with features of acceleration/transformation is difficult to define by histologic or immunohistochemical criteria. USCAP 2023 abstracts hematopathology. Laboratory Investigation. 2023;103(3):100106.
Print/Download Dr. Moore Web CV (pdf)